Article

ARVO awards and lectures

The 2005 keynote session, to be held in the Grand Floridian D in the convention center on Sunday, May 1, from 5:15 to 7:15 p.m., will feature two distinguished speakers: NIH Director Elias A. Zerhouni, MD, who will speak on "NIH: Advancing science in the 21st century," and 2003 Nobel Laureate Peter Agre, MD, who will deliver a address titled "Aquaporin water channels—From atomic structure to clinical medicine."

The 2005 keynote session, to be held in the Grand Floridian D in the convention center on Sunday, May 1, from 5:15 to 7:15 p.m., will feature two distinguished speakers: NIH Director Elias A. Zerhouni, MD, who will speak on "NIH: Advancing science in the 21st century," and 2003 Nobel Laureate Peter Agre, MD, who will deliver a address titled "Aquaporin water channels-From atomic structure to clinical medicine."

A new feature of the keynote session this year is the ARVO/Pfizer Ophthalmics Translational Research Awards. These awards, presented for excellence in translational research, will go to Peng Tee Khaw, MD, PhD, of Moorfields Hospital, for his pioneering research in the molecular regulation of wound healing that has led to the development of potential new avenues of approach to wound modulation in glaucoma filtration surgery, and Gholam Peyman, MD, of Tulane University, for his translational research bringing to clinical application numerous developments, including LASIK and a photoablative inlay for refractive surgery. He also helped to develop a pressure controlled shunt for glaucoma and developed a vitrectomy system and an endolaser probe.

The keynote session also will include presentation of the ARVO Distinguished Service Awards. Sally Atherton, PhD, Medical College of Georgia; Joseph Besharse, PhD, Medical College of Wisconsin; Oliver Braddick, PhD, University of Oxford; Henry Edelhauser, PhD, Emory University; and Terri Trotter, Emory University, will be cited for their outstanding service. Ballroom B/C/D is the planned site of the basic/clinical science lecture, "Cellular pathways in photoreceptor neurodegeneration," cosponsored by the American Association of Anatomists, at 2:30 to 4:30 p.m.

The Friedenwald Award and Lecture is slated for Tuesday, May 3, from 5:30 to 6:15 p.m. Ronald Klein, MD, MPH, and Barbara Klein, MD, MPH, from the University of Wisconsin, will receive the award and speak on "The epidemiology of eye disease: Glycemia to genetics." The Cogan Award and Lecture follows at 6:30 to 7:15 p.m. J. William Harbour, MD, from Washington University School of Medicine, will receive the award and deliver the following address: "Eye cancer: A unique insight into molecular oncogenesis." Both will take place in Ballroom B/C/D.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.